PSCA
Prostate stem cell antigen
Also known as: lncPSCA, PSCA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43653
- Gene
- PSCA
- Ensembl
- ENSG00000167653
- Chromosome
- 8
- Canonical length
- 114 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals; this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Canonical amino-acid sequenceUniProt
114 residues, UniProt reviewed canonical sequence.
>O43653|PSCA
1 MAGLALQPGT ALLCYSCKAQ VSNEDCLQVE NCTQLGEQCW TARIRAVGLL TVISKGCSLN
61 CVDDSQDYYV GKKNITCCDT DLCNASGAHA LQPAAAILAL LPALGLLLWG PGQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSCA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 3,010 nTPM
Expression across tissuesHPA
Tissue
- stomach: 3,010 nTPM
- urinary bladder: 569 nTPM
- esophagus: 341 nTPM
- prostate: 217 nTPM
- vagina: 166 nTPM
- cervix: 129 nTPM
Single-cell type
- parietal cells: 10,611 nCPM
- esophageal apical cells: 9,592 nCPM
- foveolar cells: 7,559 nCPM
- prostatic club cells: 3,522 nCPM
- salivary duct cells: 1,371 nCPM
- gastric chief cells: 1,232 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 1.4 nTPM
- hippocampal formation: 0.9 nTPM
- amygdala: 0.8 nTPM
- pons: 0.8 nTPM
- white matter: 0.8 nTPM
- basal ganglia: 0.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PSCA.
Disease | ImmuneIEDB
Conditions an epitope on PSCA was assayed in.
- prostate cancer B and T cell
- castration-resistant prostate carcinoma B and T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0.17
- gnomAD missense Z
- -0.15
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acetylcholine receptor signaling pathway
- negative regulation of ERK1 and ERK2 cascade
- regulation of neurotransmitter receptor activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSCA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSCA as an antibody target. Whether an autoantibody or antibody against PSCA could matter depends on whether native PSCA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSCA is annotated at the cell surface, where native PSCA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PSCA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...